Talent4Boards - Great Talent builds Great Boards
– IRELAND, Dublin – Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces the appointment of Mary Sheahan as a Non-Executive Director to the Board with immediate effect
Mary Blake Sheahan, aged 44, is a dedicated senior leader with over 20 years' experience, at Executive Committee level of a multinational publicly listed biopharmaceutical company.… => Read more
Venn Life Sciences appoints Mary Sheahan to the Board as Non-Executive Director
From:: Venn Life Sciences appoints Mary Sheahan to the Board as Non-Executive Director
Sorry, the comment form is closed at this time.